Tradestie Institutional Equity Comparison Engine

VENU vs MDCX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MDCX Overall Edge

MDCX Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Medicus Pharma Ltd. Common Stock (MDCX) driven by superior Growth & Margin, Momentum & Technical while VENU counters with relative strength in Options & Structure. Fundamentally, VENU trades at N/M Forward P/E with -294.7% operating margin (+2.9% YoY revenue) versus MDCX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VENU sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against MDCX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VENU N/M vs MDCX N/M Fwd P/E
Growth & Margin Winner MDCX
Op Margin -294.7% vs 0.0% ยท YoY +2.9% vs +0.0%
Momentum & Technical Winner MDCX
1Y -89.8% vs -49.3% ยท 52W Pos 1% vs 23%
Options & Structure Winner VENU
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
VENU NYSE American
Venu Holding Corporation
Services-Amusement & Recreation Services
$0.99
-3.6% 1D
Market Cap $58.3M
1M Return -23.03%
1Y Return -89.81%
Forward P/E N/M
Unified AI Score
42.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 55.0 Mom 45.0
MDCX NASDAQ
Medicus Pharma Ltd. Common Stock
Pharmaceutical Preparations
$1.14
-2.16% 1D
Market Cap $3.1M
1M Return -56.68%
1Y Return -49.33%
Forward P/E N/M
Unified AI Score
49.2 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VENU -89.81% MDCX -49.33% Spread: +40.48 pp (MDCX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VENU TTM Op. Margin: -294.7% MDCX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VENU vs MDCX. Trailing 12-month operating profitability (VENU -294.7% vs MDCX 0.0%) and valuation multiples (VENU N/M vs MDCX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VENU (4) vs MDCX (4)
Institutional Metric VENU MDCX Criterion Row Winner
Market Capitalization Scale $58.3M $3.1M Larger Scale VENU
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +2.9% +0.0% Higher Growth VENU
Operating Margin (TTM) Profitability -294.7% 0.0% Higher Margin MDCX
Net Profit Margin Profitability -281.4% 0.0% Higher Margin MDCX
Return on Equity (ROE) Capital Efficiency -24.9% -7446.1% Higher ROE VENU
52-Week Range Position Momentum 1% ($1โ€“$11) 23% ($0โ€“$5) Stronger Trend MDCX
Beta / 30D Volatility Risk Regime 1.72ฮฒ ยท 86% Vol -0.28ฮฒ ยท 118% Vol Lower Realized Risk VENU
Unified Institutional Score Composite Signal 42.3 / 100 (HOLD) 49.2 / 100 (HOLD) Higher Composite MDCX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VENU vs MDCX Buy Guide
VENU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live VENU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MDCX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MDCX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VENU nor MDCX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.